hPSCreg®
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our Privacy Policy for details. This website uses cookies, learn more

Search results

  1. UCSFi001-A-F (AICS-0106-088)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  2. ATLABi001-A (AT-MODY3-iP001)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Hepatocyte nuclear factor 1-alpha-associated monogenic diabetes

  3. ATLABi002-A (AT-MODY3-iP002)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Hepatocyte nuclear factor 1-alpha-associated monogenic diabetes

  4. ATLABi006-A (AT-UC C Normal-iC16)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Normal (average)

  5. ATLABi007-A (AT-UC C Normal-iC46)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Normal (average)

  6. ATLABi008-A (AT-UC I Normal-iC06)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Normal (average)

  7. ATLABi009-A (AT-UC I Normal-iC13)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Normal (average)

  8. ATLABi010-A (AT-MODY10-iII1)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Maturity-onset diabetes of the young type 10

  9. ATLABi011-A (AT-MODY10-iII4)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Maturity-onset diabetes of the young type 10

  10. ATLABi012-A (AT-M10 Normal-iI2)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Normal (average)

  11. ATLABi013-A (AT-M10 Normal-iII3)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Normal (average)

  12. ATLABi014-A (AT-MODY10-iI1)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Maturity-onset diabetes of the young type 10

  13. AUMCi010-F (LUMC0255iHCM06 and LF2A_C06)

    Netherlands Amsterdam University Medical Centers (AUMC)
    Disease:

    Hypertrophic cardiomyopathy

  14. AUMCi011-F (LUMC0258iHCM06 and LF2B_C06)

    Netherlands Amsterdam University Medical Centers (AUMC)
    Disease:

    Hypertrophic cardiomyopathy

  15. AUMCi012-F (LUMC0281iHCM06 and LF3A_C06)

    Netherlands Amsterdam University Medical Centers (AUMC)
    Disease:

    Hypertrophic cardiomyopathy

  16. AUMCi013-F (LF3B_C14 and LUMC0282iHCM14)

    Netherlands Amsterdam University Medical Centers (AUMC)
    Disease:

    Hypertrophic cardiomyopathy

  17. AUMCi014-F (LUMC0283iHCM06 and LF3C_C06)

    Netherlands Amsterdam University Medical Centers (AUMC)
    Disease:

    Hypertrophic cardiomyopathy

  18. BCHi011-A (HNDS0003-01 #F)

    United States Children's Hospital (BCH)
    Disease:

    Succinic semialdehyde dehydrogenase deficiency

  19. BCHi011-A-1 (HNDS0003-01 #F CC39 +/+)

    United States Children's Hospital (BCH)
    Disease:

    Succinic semialdehyde dehydrogenase deficiency

  20. BCHi032-A-1 (HNDS0038-01#A Pass-Match-Control)

    United States Children's Hospital (BCH)
    Disease:

    Foxg1 syndrome

  21. BCHi034-A (HNDS0181-01#F)

    United States Children's Hospital (BCH)
    Disease:

    Foxg1 syndrome

  22. BCHi034-A-1 (HNDS0181-01#F CNC27(+/-))

    United States Children's Hospital (BCH)
    Disease:

    Foxg1 syndrome

  23. BCHi034-A-2 (HNDS0181-01#F CNC33(+/-))

    United States Children's Hospital (BCH)
    Disease:

    Foxg1 syndrome

  24. BCHi034-A-3 (HNDS0181-01#F CC2(+/+))

    United States Children's Hospital (BCH)
    Disease:

    Foxg1 syndrome

  25. BCHi034-A-4 (HNDS0181-01#F CC7(+/+))

    United States Children's Hospital (BCH)
    Disease:

    Foxg1 syndrome

  26. BCHi046-A-3 (HNDS0069-01#B Pass-Match-Control)

    United States Children's Hospital (BCH)
    Disease:

    Developmental and epileptic encephalopathy 7

  27. BCMi001-A (M22c5 and HSCC-003iPS-Sc5)

    United States Baylor College of Medicine (BCM)
    Disease:

    Normal (average)

  28. BCMi001-B (M22c8 and HSCC-003iPS-Sc8)

    United States Baylor College of Medicine (BCM)
    Disease:

    Normal (average)

  29. WIBRe001-A-9 (WIBR3_FBXO7_R498X_A7-1)

    United States University of California, Berkeley (CAL)
    Disease:

    Parkinson disease

  30. WIBRe001-A-10 (WIBR3_FBXO7_FS_A3-1)

    United States University of California, Berkeley (CAL)
    Disease:

    Parkinson disease

  31. CHAe001-A (CHA-hES3)

    South Korea Pochon CHA University (CHA)

  32. CSCIi001-A (niPSC HDF16 and niPSC-16.2b)

    United Kingdom Wellcome Trust - MRC Stem Cell Institute (CSCI)
    Disease:

    Normal (average)

  33. CSCIi002-A (niPSC HDF75 and niPSC-75.1c2)

    United Kingdom Wellcome Trust - MRC Stem Cell Institute (CSCI)
    Disease:

    Normal (average)

  34. CSUe004-A (chHES-20)

    China Central South University (CSU)

  35. CSUe005-A (chHES-22)

    China Central South University (CSU)

  36. WAe009-A-10 (EBNA1+H9 and H9-EBNA)

    China Central South University (CSU)
    Disease:

    Normal (average)

  37. DALCe001-A (ReliCellhES1)

    India Dhirubhai Ambani Life Sciences Center (DALC)

  38. DANi006-F (GBA-006-C6)

    Denmark Danish Research Institute of Translational Neuroscience (DAN)
    Disease:

    Parkinson disease

  39. DANi008-F (SNCA-008-C6)

    Denmark Danish Research Institute of Translational Neuroscience (DAN)
    Disease:

    Parkinson disease

  40. EHTJUi007-A (DFGMP-ZB11AO-F)

    China East Hospital Affiliated to Tongji University (EHTJU)
    Disease:

    Normal (average)

  41. ESi049-A (MS FiPS 2 R4F-10)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Obsolete_multiple sclerosis

  42. ESi050-A (MS FiPS 3-R4F-1)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Multiple sclerosis

  43. ESi051-A (MS FiPS 4-R4F-1)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Obsolete_multiple sclerosis

  44. ESi052-A (MS FiPS 5-R4F-6)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Multiple sclerosis

  45. ESi053-A (MS FiPS 6-R4F-2)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Multiple sclerosis

  46. ESi068-A (SWB FiPS 159-R4F-4)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Williams-beuren syndrome

  47. ESi069-A (SWB FiPS 344-R4F-2)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Williams-beuren syndrome

  48. ESi070-A (DUPSW FiPS 501-R4F-2)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Autism

  49. ESi071-A (DUPSW FiPS 701-R4F-6)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Autism

  50. ESi094-A (Hz 1-8-3 CBiPS4 Sv4F F6)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (average)

  51. FDCHDPi001-A (FDCHDP01)

    China Fudan University (FDCHDP)
    Disease:

    Tourette syndrome

  52. FDIBSi001-A (iPSCx-x-ADNP-F)

    China Institutes of Brain Science,Fudan University (FDIBS)
    Disease:

    Adnp-related multiple congenital anomalies - intellectual disability - autism spectrum disorder

  53. FSMi001-A (FSM-SPG31-2)

    Italy IRCCS Fondazione Stella Maris (FSM)
    Disease:

    Spastic paraplegia 31

  54. GENEAe001-A (GENEA001 and SIVF01)

    Australia Genea (GENEA)
    Disease:

    Normal (average)

  55. GENEAe002-A (GENEA003 and SIVF03)

    Australia Genea (GENEA)

  56. GENEAe003-A (SIVF04 and GENEA004)

    Australia Genea (GENEA)

  57. GENEAe004-A (SIVF05 and GENEA005)

    Australia Genea (GENEA)

  58. GENEAe005-A (SIVF06 and GENEA006)

    Australia Genea (GENEA)

  59. GENEAe006-A (SIVF07 and GENEA007)

    Australia Genea (GENEA)

  60. GENEAe007-A (GENEA008 and SIVF08)

    Australia Genea (GENEA)

  61. GENEAe008-A (GENEA009 and SIVF09)

    Australia Genea (GENEA)

  62. GENEAe009-A (SIVF10 and GENEA010)

    Australia Genea (GENEA)

  63. GENEAe010-A (SIVF11 and GENEA011)

    Australia Genea (GENEA)

  64. GENEAe011-A (SIVF12 and GENEA012)

    Australia Genea (GENEA)

  65. GENEAe012-A (SIVF13 and GENEA013)

    Australia Genea (GENEA)

  66. GENEAe014-A (GENEA029)

    United States Genea (GENEA)
    Disease:

    Normal (average)

  67. HCORDi001-F (M2_IPSC3_M)

    Brazil Hemocord Clínica Médica Ltda (HCORD)
    Disease:

    Normal (average)

  68. HPIi013-A (OPDM_ABCD3)

    Australia Harry Perkins Institute of Medical Research (HPI)
    Disease:

    Oculopharyngodistal myopathy

  69. IBPi001-A (HPrF iPSCs 20A)

    Czech Republic Institute of Biophysics of the Czech Academy of Sciences (IBP)
    Disease:

    Normal (average)

  70. ICGi022-A-1 (SOD1-G128R_K7-4L-f and SOD1-G128R)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Healthy subject

  71. ICGi030-A (HF2)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Wilson disease

  72. IMBPASi001-A (iPSC-WFS1-#1)

    Poland Institute of Medical Biology of Polish Academy of Sciences (IMBPAS)
    Disease:

    Wolfram syndrome 1

  73. INNDSUi001-A (186-Nml-F-24)

    China Institute of Neuromuscular and Neurodegenerative Diseases, Shandong University (INNDSU)
    Disease:

    Normal (average)

  74. INPERe001-A (Amicqui-1, Amicqui1 and Amiqui1)

    Mexico Instituto Nacional de Perinatología (INPER)
    Disease:

    Normal (average)

  75. INPERe002-A (Amicqui-2)

    Mexico Instituto Nacional de Perinatología (INPER)
    Disease:

    Normal (average)

  76. KAUSTi008-F (KS4-iPSC#F)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Klinefelter's syndrome

  77. WAe001-A-F (H1X-59/H1.4-5)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  78. KMUGMCi006-F (TS271 #20 MT)

    Japan Kanazawa Medical University (KMUGMC)
    Disease:

    Tuberous sclerosis

  79. KUIMSe001-A (KhES-1)

    Japan Kyoto University (KUIMS)
    Disease:

    Normal (average)

  80. KUIMSe002-A (KhES-2)

    Japan Kyoto University (KUIMS)

  81. KUIMSe003-A (KhES-3)

    Japan Kyoto University (KUIMS)

  82. KUIMSe003-A-1

    Japan Kyoto University (KUIMS)

  83. LUMCi054-A (CRB1 patient c.3122T>C p.(Met1041Thr) homozygote and LUMC0116iCRB09)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Retinitis pigmentosa

  84. LUMCi054-A-1 (LUMC0116iCRB09 ISO-02, LUMC0116iCRB09 homozygote CRISPR corrected isogenic clone 02 and iso02LUMC0116iCRB09)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Retinitis pigmentosa

  85. LUMCi054-A-2 (LUMC0116iCRB09 ISO-03, LUMC0116iCRB09 heterozygote CRISPR corrected isogenic clone 03 and iso03LUMC0116iCRB09)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Retinitis pigmentosa

  86. LUMCi055-A (CRB1 patient 117 compound heterozygous 2983G>T p.(Glu995*) c.1892A>G, p.(Tyr631Cys) and LUMC0117iCRB01)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Retinitis pigmentosa

  87. LUMCi056-A (CRB1 patient 128 compound heterozygous c.2843G>A p.(Cys948Tyr) and c.3122T>C p.(Met1041Thr) and LUMC0128iCRB01)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Retinitis pigmentosa

  88. LUMCi056-A-1 (LUMC0128iCRB01 heterozygote CRISPR corrected isogenic clone 02 and iso02LUMC0128iCRB01)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Retinitis pigmentosa

  89. LVPEIi001-B (LVIP02-NC-F2-1)

    India L.V. Prasad Eye Institute (LVPEI)
    Disease:

    Normal (average)

  90. LVPEIi002-A (LVIP02-RB-1)

    India L.V. Prasad Eye Institute (LVPEI)
    Disease:

    Retinoblastoma

  91. LVPEIi004-A (LVIP02-LC2-1)

    India L.V. Prasad Eye Institute (LVPEI)
    Disease:

    Leber congenital amaurosis 2

  92. LVPEIi005-A (LVIP02-LC2-2)

    India L.V. Prasad Eye Institute (LVPEI)
    Disease:

    Leber congenital amaurosis 2

  93. LVPEIi006-A (LVIP02-LC12-1)

    India L.V. Prasad Eye Institute (LVPEI)
    Disease:

    Leber congenital amaurosis 12

  94. LVPEIi008-A (LVIP02-SD1-2)

    India L.V. Prasad Eye Institute (LVPEI)
    Disease:

    Stargardt disease

  95. MCRIi001-A-1 (PB001-OI26)

    Australia Murdoch Children's Research Institute (MCRI)
    Disease:

    Osteogenesis imperfecta

  96. MIZMe004-A (Miz-hES9)

    South Korea MizMedi Hospital (MIZM)

  97. MIZMe005-A (Miz-hES14)

    South Korea MizMedi Hospital (MIZM)

  98. MIZMe006-A (Miz-hES15)

    South Korea MizMedi Hospital (MIZM)

  99. MIZMe007-A (Miz-hES4)

    South Korea MizMedi Hospital (MIZM)

  100. MIZMe008-A (Miz-hES5)

    South Korea MizMedi Hospital (MIZM)

  101. MIZMe009-A (Miz-hES6)

    South Korea MizMedi Hospital (MIZM)

  102. MIZMe010-A (Miz-hES7)

    South Korea MizMedi Hospital (MIZM)

  103. MIZMe011-A (Miz-hES8)

    South Korea MizMedi Hospital (MIZM)

  104. MIZMe012-A (Miz-hES10)

    South Korea MizMedi Hospital (MIZM)

  105. MIZMe013-A (Miz-hES11)

    South Korea MizMedi Hospital (MIZM)

  106. MIZMe014-A (Miz-hES12)

    South Korea MizMedi Hospital (MIZM)

  107. MIZMe015-A (Miz-hES13)

    South Korea MizMedi Hospital (MIZM)
    Disease:

    Patau syndrome

  108. MUNIe001-A (CCTL 6)

    Czech Republic Masaryk University (MUNI)

  109. MUNIe001-A-1

    Czech Republic Masaryk University (MUNI)

  110. MUNIe002-A (CCTL 8)

    Czech Republic Masaryk University (MUNI)

  111. MUNIe002-A-1

    Czech Republic Masaryk University (MUNI)

  112. MUNIe003-A (CCTL 9)

    Czech Republic Masaryk University (MUNI)

  113. MUNIe003-A-1

    Czech Republic Masaryk University (MUNI)

  114. MUNIe004-A (CCTL 10)

    Czech Republic Masaryk University (MUNI)

  115. MUNIe004-A-1

    Czech Republic Masaryk University (MUNI)

  116. MUNIe005-A (CCTL 12)

    Czech Republic Masaryk University (MUNI)

  117. MUNIe005-A-1

    Czech Republic Masaryk University (MUNI)

  118. MUNIe006-A (CCTL 13)

    Czech Republic Masaryk University (MUNI)

  119. MUNIe006-A-1

    Czech Republic Masaryk University (MUNI)

  120. MUNIe007-A (CCTL 14)

    Czech Republic Masaryk University (MUNI)

  121. MUSCSDi001-A (iPSK3)

    United States Steve's Duncan Lab (MUSCSD)
    Disease:

    Normal (average)

  122. NERCe002-A (chHES-90)

    China National Engineering and Research Center of Human Stem Cell (NERC)
    Disease:

    Normal (average)

  123. NERCe002-A-1 (chHES-90-PLEX-ZsGreen)

    China National Engineering and Research Center of Human Stem Cell (NERC)
    Disease:

    Normal (average)

  124. NERCe002-A-2 (chHES-90-PLEX-Luciferase)

    China National Engineering and Research Center of Human Stem Cell (NERC)
    Disease:

    Normal (average)

  125. NERCe002-A-3 (chHES-90-pINDUCER20-tet-14-3-3ζ)

    China National Engineering and Research Center of Human Stem Cell (NERC)
    Disease:

    Normal (average)

  126. NERCe003-A-1 (chHES-8-pINDUCER20-tet-CTNNB1)

    China National Engineering and Research Center of Human Stem Cell (NERC)
    Disease:

    Normal (average)

  127. NERCe003-A-2 (chHES-8-pINDUCER10-tet-shβ-catenin)

    China National Engineering and Research Center of Human Stem Cell (NERC)
    Disease:

    Normal (average)

  128. NERCe003-A-3 (chHES-8-KO-P53)

    China National Engineering and Research Center of Human Stem Cell (NERC)
    Disease:

    Normal (average)

  129. NIMHi001-A

    India National Institute of Mental Health and Neurosciences (NIMH)
    Disease:

    Obsolete_parkinson's disease

  130. NIMHi002-A (BPPD02)

    India National Institute of Mental Health and Neurosciences (NIMH)
    Disease:

    Parkinson disease

  131. NIMHi003-A

    India National Institute of Mental Health and Neurosciences (NIMH)
    Disease:

    Parkinson disease

  132. NIMHi004-A

    India National Institute of Mental Health and Neurosciences (NIMH)
    Disease:

    Normal (average)

  133. NIMHi005-A

    India National Institute of Mental Health and Neurosciences (NIMH)
    Disease:

    Normal (average)

  134. NIMHi006-A

    India National Institute of Mental Health and Neurosciences (NIMH)
    Disease:

    Normal (average)

  135. NIMHi015-A

    India National Institute of Mental Health and Neurosciences (NIMH)
    Disease:

    Autosomal recessive juvenile parkinson disease 2

  136. NIMHi018-A (PD07)

    India National Institute of Mental Health and Neurosciences (NIMH)
    Disease:

    Parkinson's disease 6

  137. RCi002-A (FP5C-14 and RCi92)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Primary erythromelalgia

  138. RCi002-B (FP5C-16 and RCi93)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Primary erythromelalgia

  139. RIi001-A (R.1.H.iPSC.1)

    Iran Royan Institute (RI)

  140. RIi002-A (BOM.1.H.iPSC.1)

    Iran Royan Institute (RI)
    Disease:

    Normal (average)

  141. RIi003-A (FHC.1.H.iPSC.3)

    Iran Royan Institute (RI)
    Disease:

    Familial hypercholesterolemia

  142. RIi004-A (GSD.1.H.iPSC.7)

    Iran Royan Institute (RI)
    Disease:

    Glycogen storage disease

  143. RIi005-A (TYR.1.H.iPSC.1)

    Iran Royan Institute (RI)
    Disease:

    Tyrosinemia type 1

  144. RIi006-A (HER.1.H.iPSC.1)

    Iran Royan Institute (RI)
    Disease:

    Cholestasis

  145. RIi007-A (R.1.H.iPSC.4)

    Iran Royan Institute (RI)

  146. RIi008-A (R.1.H.iPSC.9)

    Iran Royan Institute (RI)

  147. RIi009-A (RP2.H.iPSC.3)

    Iran Royan Institute (RI)
    Disease:

    Retinitis pigmentosa

  148. RIi010-A (LCA.1.H.iPSC.1)

    Iran Royan Institute (RI)
    Disease:

    Leber congenital amaurosis

  149. RIi011-A (USH.1.H.iPSC.6)

    Iran Royan Institute (RI)
    Disease:

    Usher syndrome

  150. RIi012-A (RP.1.H.iPSC.2)

    Iran Royan Institute (RI)
    Disease:

    Retinitis pigmentosa

  151. RIi013-A (ARMD.1.H.iPSC.2)

    Iran Royan Institute (RI)
    Disease:

    Age-related macular degeneration

  152. RIi014-A (LHON.1.H.iPSC.5)

    Iran Royan Institute (RI)
    Disease:

    Leber congenital amaurosis

  153. RIi015-A (CNS.1.H.iPSC.10)

    Iran Royan Institute (RI)
    Disease:

    Crigler-najjar syndrome

  154. RIi016-A (CNS.2.H.iPSC.7)

    Iran Royan Institute (RI)
    Disease:

    Crigler-najjar syndrome

  155. SALKe001-A (Cyth25)

    United States The Salk Institute for Biological Studies (SALK)

  156. SNUe004-A (SNUhES4)

    South Korea Seoul National University (SNU)
    Disease:

    Normal (average)

  157. SNUe004-A-1

    South Korea Seoul National University (SNU)
    Disease:

    Normal (average)

  158. SNUe005-A (SNUhES11)

    South Korea Seoul National University (SNU)

  159. SNUe005-A-1

    South Korea Seoul National University (SNU)

  160. SNUe006-A (SNUhES16)

    South Korea Seoul National University (SNU)

  161. SNUe006-A-1

    South Korea Seoul National University (SNU)

  162. SSMUe003-A (SH7)

    China Shanghai Second Medical University (SSMU)

  163. SSMUe004-A (SH4)

    China Shanghai Second Medical University (SSMU)

  164. SSMUe005-A (SH28)

    China Shanghai Second Medical University (SSMU)

  165. SSMUe006-A (SH35 and SH35a)

    China Shanghai Second Medical University (SSMU)

  166. SSMUe008-A (SH38)

    China Shanghai Second Medical University (SSMU)

  167. SSMUe009-A (SH39)

    China Shanghai Second Medical University (SSMU)

  168. SSMUe010-A (SH42)

    China Shanghai Second Medical University (SSMU)

  169. TISSUi001-A (HUMIMIC101, StemUse101 and SU101)

    Germany TissUse GmbH (TISSU)
    Disease:

    Normal (average)

  170. TNRMCi001-A (iTAF32)

    Russia Tomsk National Research Medical Center of the Russian Academy of Sciences (TNRMC)
    Disease:

    Cystic fibrosis

  171. UAZTi011-A (MKAZ3)

    United States University of Arizona (UAZT)
    Disease:

    Pontocerebellar hypoplasia type 1b

  172. UKHGi002-A (F-PKE (2))

    Germany Institute of Human Genetics Heidelberg (UKHG)
    Disease:

    Normal (average)

  173. UKHGi002-B (F-PKE (3))

    Germany Institute of Human Genetics Heidelberg (UKHG)
    Disease:

    Normal (average)

  174. UKMi009-A (HCN4 K1 homo)

    Germany University Hospital Muenster (UKM)
    Disease:

    Sick sinus syndrome

  175. UKMi011-A (HCN4 K1 hetero)

    Germany University Hospital Muenster (UKM)
    Disease:

    Sick sinus syndrome

  176. ULBi002-A (Hel115.6)

    Belgium Université Libre de Bruxelles (ULB)
    Disease:

    Normal (average)

  177. UNIBSi017-A (EDS-iPSC)

    Italy University of Brescia (UNIBS)

  178. UPSFRi001-A (PB03)

    France Université Paris-Sud 11 (UPSFR)

  179. UPSFRi002-A (PB04)

    France Université Paris-Sud 11 (UPSFR)
    Disease:

    Beta thalassemia

  180. UPSFRi003-A (PB05-1)

    France Université Paris-Sud 11 (UPSFR)
    Disease:

    Beta thalassemia

  181. UPSFRi004-A (PB05)

    France Université Paris-Sud 11 (UPSFR)
    Disease:

    Beta thalassemia

  182. UPSFRi004-A-1 (PB05-1)

    France Université Paris-Sud 11 (UPSFR)
    Disease:

    Beta thalassemia

  183. UPSFRi005-A (PB06)

    France Université Paris-Sud 11 (UPSFR)
    Disease:

    Down syndrome

  184. UPSFRi005-A-1 (PB06-1)

    France Université Paris-Sud 11 (UPSFR)
    Disease:

    Down syndrome

  185. UPSFRi006-A (PB07)

    France Université Paris-Sud 11 (UPSFR)

  186. UPSFRi007-A (PB08)

    France Université Paris-Sud 11 (UPSFR)

  187. UPSFRi008-A (PB09)

    France Université Paris-Sud 11 (UPSFR)

  188. UPSFRi009-A (PB10)

    France Université Paris-Sud 11 (UPSFR)

  189. UPSFRe001-A (CL01)

    France Université Paris-Sud 11 (UPSFR)
    Disease:

    Chromosomal disease

  190. UPSFRe002-A (CL02)

    France Université Paris-Sud 11 (UPSFR)
    Disease:

    Monogenic disease

  191. UPSFRe003-A (CL03)

    France Université Paris-Sud 11 (UPSFR)
    Disease:

    Chromosomal disease

  192. VIACe001-A (hESBGN-01 (BG01))

    United States Novocell, Inc. (VIAC)

  193. VIACe001-A-2 (BG01V)

    United States Novocell, Inc. (VIAC)
    Disease:

    Klinefelter syndrome

  194. VIACe002-A (hESBGN-02 (BG02))

    United States Novocell, Inc. (VIAC)

  195. VIACe003-A (hESBGN-03 (BG03))

    United States Novocell, Inc. (VIAC)

  196. WAe001-A (WA01 and H1)

    United States WiCell Research Institute (WA)
    Disease:

    Normal (average)

  197. WAe007-A (H7 and WA07)

    United States WiCell Research Institute (WA)
    Disease:

    Normal (average)

  198. WAe013-A (WA13 and H13)

    United States WiCell Research Institute (WA)

  199. WAe014-A (WA14 and H14)

    United States WiCell Research Institute (WA)

  200. WTSIi001-A (HPSI1213i-pahc_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  201. WTSIi037-A (HPSI0114i-zoxy_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  202. WTSIi038-A (HPSI1113i-ieki_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  203. WTSIi046-B (HPSI0214i-wibj_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  204. WTSIi047-B (HPSI0814i-bokz_6)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  205. WTSIi049-A (HPSI0514i-wiii_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  206. WTSIi049-B (HPSI0514i-wiii_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  207. WTSIi052-A (HPSI1114i-ziyn_6)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  208. WTSIi053-A (HPSI0413i-corn_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  209. WTSIi054-B (HPSI0413i-nudd_6)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  210. WTSIi056-A (HPSI0513i-dipe_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  211. WTSIi057-B (HPSI0513i-giuf_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  212. WTSIi059-A (HPSI0513i-uilw_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  213. WTSIi063-A (HPSI0613i-aevs_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  214. WTSIi068-B (HPSI0613i-giuo_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  215. WTSIi069-A (HPSI0613i-hegp_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  216. WTSIi073-A (HPSI0314i-sojd_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  217. WTSIi082-A (HPSI1013i-cups_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  218. WTSIi083-A (HPSI1213i-xuja_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  219. WTSIi085-A (HPSI1113i-eofe_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  220. WTSIi086-A (HPSI0913i-coyi_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  221. WTSIi098-A (HPSI1213i-nekd_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  222. WTSIi102-A (HPSI0413i-iakz_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  223. WTSIi102-B (HPSI0413i-iakz_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  224. WTSIi103-A (HPSI1213i-nusw_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  225. WTSIi104-A (HPSI0513i-coio_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  226. WTSIi104-B (HPSI0513i-coio_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  227. WTSIi105-A (HPSI0313i-airc_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  228. WTSIi105-B (HPSI0313i-airc_66)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  229. WTSIi106-B (HPSI0613i-hikj_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  230. WTSIi109-A (HPSI0413i-coxy_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  231. WTSIi109-B (HPSI0413i-coxy_33)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  232. WTSIi110-A (HPSI0713i-darw_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  233. WTSIi111-A (HPSI0513i-euir_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  234. WTSIi112-A (HPSI0613i-funp_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  235. WTSIi114-A (HPSI0513i-golb_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  236. WTSIi115-A (HPSI0513i-iasn_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  237. WTSIi116-A (HPSI0813i-iicq_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  238. WTSIi117-A (HPSI0613i-liun_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  239. WTSIi118-A (HPSI0813i-meqo_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  240. WTSIi119-A (HPSI0613i-oefg_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  241. WTSIi120-A (HPSI0513i-oeoo_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  242. WTSIi121-A (HPSI0413i-ougl_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  243. WTSIi121-B (HPSI0413i-ougl_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  244. WTSIi122-A (HPSI0413i-peop_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  245. WTSIi123-A (HPSI0713i-qimz_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  246. WTSIi124-A (HPSI0713i-ruyv_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  247. WTSIi124-B (HPSI0713i-ruyv_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  248. WTSIi125-A (HPSI0413i-uahf_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  249. WTSIi126-A (HPSI0913i-vopm_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  250. WTSIi127-A (HPSI0413i-xekf_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  251. WTSIi128-A (HPSI0413i-yuze_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  252. WTSIi129-A (HPSI0613i-zisa_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  253. WTSIi130-A (HPSI0713i-aehn_22)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  254. WTSIi131-A (HPSI0513i-aipt_33)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  255. WTSIi133-A (HPSI0713i-dard_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  256. WTSIi133-B (HPSI0713i-dard_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  257. WTSIi134-B (HPSI0513i-dulv_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  258. WTSIi137-A (HPSI0613i-lizq_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  259. WTSIi137-B (HPSI0613i-lizq_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  260. WTSIi138-A (HPSI0414i-mita_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  261. WTSIi139-A (HPSI1113i-oaaz_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  262. WTSIi140-A (HPSI0613i-oomz_22)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  263. WTSIi141-A (HPSI0613i-qanu_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  264. WTSIi142-A (HPSI0613i-qony_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  265. WTSIi144-A (HPSI0114i-wegi_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  266. WTSIi145-A (HPSI0813i-wots_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  267. WTSIi146-A (HPSI0613i-xosg_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  268. WTSIi168-A (HPSI0214i-poih_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  269. WTSIi168-B (HPSI0214i-poih_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  270. WTSIi169-A (HPSI0614i-miaj_6)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  271. WTSIi170-B (HPSI1213i-tolg_6)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  272. WTSIi171-A (HPSI0914i-zerv_7)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  273. WTSIi171-B (HPSI0914i-zerv_8)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  274. WTSIi172-A (HPSI0914i-laey_6)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  275. WTSIi172-B (HPSI0914i-laey_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  276. WTSIi173-A (HPSI0414i-naju_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  277. WTSIi174-A (HPSI0614i-paab_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  278. WTSIi175-A (HPSI1014i-tixi_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  279. WTSIi176-B (HPSI0714i-iudw_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  280. WTSIi177-A (HPSI0414i-xojn_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  281. WTSIi178-B (HPSI0215i-fawm_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  282. WTSIi179-A (HPSI0314i-wigw_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  283. WTSIi180-A (HPSI0514i-puie_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  284. WTSIi180-B (HPSI0514i-puie_5)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  285. WTSIi181-A (HPSI0514i-rutc_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  286. WTSIi182-A (HPSI0614i-kegd_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  287. WTSIi183-A (HPSI0414i-oaqd_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  288. WTSIi183-B (HPSI0414i-oaqd_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  289. WTSIi184-A (HPSI1014i-qayj_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  290. WTSIi184-B (HPSI1014i-qayj_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  291. WTSIi186-A (HPSI1014i-babz_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  292. WTSIi187-A (HPSI1013i-sita_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  293. WTSIi188-A (HPSI1014i-kefb_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  294. WTSIi189-A (HPSI1014i-quls_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  295. WTSIi190-A (HPSI0914i-kajh_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  296. WTSIi191-A (HPSI0215i-oilg_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  297. ZZUNEUi010-A (CMF001-A)

    China ZhengZhou University- The first affiliated hospital(ZZU) (ZZUNEU)
    Disease:

    Juvenile amyotrophic lateral sclerosis